Pfizer and Medivation reportedly close to $14bn deal

Home › Pfizer and Medivation reportedly close to $14bn deal

US pharmaceutical giant Pfizer is reportedly in advanced talks to buy cancer drug firm Medivation for about $14bn (10.7bn).

23.11	'Trust and reserve judgement' on rebrand, says Jaguar
23.11	UK wants to hire EU negotiator to 'reset' relations
23.11	Sisters build global beauty brand from a garage
23.11	Versace bag for 15: Why Christmas shoppers are choosing charity shops
23.11	'We are being robbed': Homeowners feel trapped by rising fees
22.11	'Scammers sent courier to steal 4,000'
22.11	Spain fines budget airlines including Ryanair 179m
22.11	Formulating Biphasic and Triphasic Products
Consumer Goods and Services »

je.st